Skip to main content

Aerobic Exercise

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Verona Pharma
Verona PharmaUK - London
1 program
TrainingN/A2 trials
Active Trials
NCT07878702Not Yet Recruiting30Est. Sep 2029
NCT04758754Unknown36Est. Dec 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
2029
Verona PharmaTraining
Verona PharmaTraining

Clinical Trials (2)

Total enrollment: 66 patients across 2 trials

Dual-Task Balance Training in People With Multiple Sclerosis: a Randomized Feasibility Study

Start: Oct 2026Est. completion: Sep 202930 patients
N/ANot Yet Recruiting

Active and Passive Exercise Training in Improving Vascular Function: Local vs Systemic Vascular Effect.

Start: Dec 2023Est. completion: Dec 202436 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.